The Biological and Emerging Infections Research Resources Program (BEI-RRP)

This pre-solicitation notice is for the Biological and Emerging Infections Research Resource Program to be awarded by the National Institute of Allergy and Infectious Diseases. The program will provide approximately 17,000 unique organisms and reagents related to infectious diseases including Category A, B and C priority pathogens, emerging infectious diseases, HIV/AIDS and non-pathogenic microbes. Services will include acquiring, storing, authenticating, producing, distributing and deaccessioning research materials under Good Laboratory Practices and appropriate biosafety level conditions. It is estimated that 54.75 full-time equivalents will be required to support approximately 12,000 registered users. The cost-reimbursement contract has a one-year base period and six one-year options, with an anticipated award date of March 1, 2023. The request for proposal will be available on December 23, 2021 through the NIAID electronic submission website.

There is no set-aside designation. The NAICS code is 541711 and PSC code is R421. The incumbent contractor is Charles River Laboratories. The contract value is estimated at $150M over seven years. Services will support approximately 12,000 registered users with 17,000 unique organisms and reagents.